Daptomycin vs Theta-Defensin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic from Streptomyces roseosporus, FDA-approved in 2003. It has a novel mechanism of action distinct from all other approved antibiotics: calcium-dependent insertion into bacterial membranes followed by channel formation and rap...
Calculate Daptomycin dose →Theta-defensins are the only known cyclic peptides produced in the animal kingdom. Found in rhesus macaques and other Old World primates, they are formed by ligation of two 9-residue alpha-defensin gene products into an 18-residue macrocyclic structure....
Calculate Theta-Defensin dose →| Parameter | Daptomycin | Theta-Defensin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Preclinical |
| Half-Life | 8-9 hours | Extended (cyclic stability) |
| Typical Dose | 4-6 mg/kg IV once daily (skin); 6-10 mg/kg IV once daily (bacteremia) | N/A (research only) |
| Frequency | Once daily IV | N/A |
| Route | IV | Systemic (research) |
| FDA Status | Approved (MRSA skin, bacteremia, right-sided endocarditis, 2003) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.